TRAF Family Member-Associated NF-κB Activator (TANK) Induced by RANKL Negatively Regulates Osteoclasts Survival and Function

TRAF Family Member-Associated NF-κB Activator (TANK) Induced by RANKL Negatively Regulates Osteoclasts Survival and Function

<p>Osteoclasts are the principle bone-resorbing cells. Precise control of balanced osteoclast activity is indispensable for bone homeostasis. Osteoclast activation mediated by RANK-TRAF6 axis has been clearly identified. However, a negative regulation-machinery in osteoclast remains unclear. T...

Full description

Bibliographic Details
Main Author:	Mengrui Wu, Yiping Wang, Lianfu Deng, Wei Chen, Yi-Ping Li
Format:	Article
Language:	English
Published:	Ivyspring International Publisher 2012-01-01
Series:	International Journal of Biological Sciences
Online Access:	http://www.biolsci.org/v08p1398.htm

Similar Items

Carbon Monoxide Inhibits Receptor Activator of NF-κB (RANKL)-Induced Osteoclastogenesis
by: Feng-Jen Tseng, et al.
Published: (2015-07-01)

RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer.
by: Lau, Y, et al.
Published: (2007)

Osteoclast differentiation in Paget's disease is hypersensitive to RANKL.
by: Neale, S, et al.
Published: (2000)

Polyphyllin VII attenuated RANKL-induced osteoclast differentiation via inhibiting of TRAF6/c-Src/PI3K pathway and ROS production
by: Long Zhou, et al.
Published: (2020-02-01)

Plumbagin modulates RANKL-induced osteoclast and osteoblast differentiation
by: Soni Ghumnani, et al.
Published: (2023-05-01)

Beneficial effect of pristimerin against the development of osteoporosis in ovariectomy-induced osteoporosis rats by the RANKL/TRAF6/NF-κB pathway
by: Wei Xu, et al.
Published: (2019-07-01)

Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption
by: Brendan F. Boyce, et al.
Published: (2018-09-01)

TRAF Family Member 4 Promotes Cardiac Hypertrophy Through the Activation of the AKT Pathway
by: Jian Li, et al.
Published: (2023-09-01)

Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation
by: Lili Wu, et al.
Published: (2019-12-01)

SHARPIN negatively associates with TRAF2-mediated NFκB activation.
by: Yanhua Liang
Published: (2011-01-01)

Clathrin-dependent endocytosis of membrane-bound RANKL in differentiated osteoclasts
by: P. Narducci, et al.
Published: (2010-03-01)

Magnolol Inhibits Osteoclast Differentiation via Suppression of RANKL Expression
by: Youn-Hwan Hwang, et al.
Published: (2018-07-01)

Amyloid β Peptide Enhances RANKL-Induced Osteoclast Activation through NF-κB, ERK, and Calcium Oscillation Signaling
by: Shangfu Li, et al.
Published: (2016-10-01)

RANKL and M-CSF are required for osteoclast differentiation by macrophages in breast cancer
by: Danks, L, et al.
Published: (2003)

Involvement of RANKL-dependent/independent mechanisms in osteoclast formation in aseptic loosening
by: Sabokbar, A, et al.
Published: (2001)

Transforming growth factor-beta induces osteoclast formation in the absence of RANKL.
by: Itonaga, I, et al.
Published: (2004)

α-1 Antitrypsin Inhibits RANKL-induced Osteoclast Formation and Functions
by: Mohammad Ahsanul Akbar, et al.
Published: (2017-03-01)

Flavopiridol Protects Bone Tissue by Attenuating RANKL Induced Osteoclast Formation
by: Zi’ang Hu, et al.
Published: (2018-05-01)

Spi-C positively regulates RANKL-mediated osteoclast differentiation and function
by: Eun Mi Go, et al.
Published: (2020-04-01)

ELMO1 Regulates RANKL-Stimulated Differentiation and Bone Resorption of Osteoclasts
by: Xinyue Liang, et al.
Published: (2021-07-01)

Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-κB and AKT signalling pathways and promotes Caspase3-mediated apoptosis of mature osteoclasts
by: Liuliu Yan, et al.
Published: (2019-06-01)

Madecassic acid suppresses osteoclast differentiation and bone resorption by inhibiting RANKL‐induced NF‐κB, JNK and NFAT signaling pathways
by: Peiru Su, et al.
Published: (2023-12-01)

High expression of TRAF4 in hepatocelullar carcinoma as an independent negative survival and recurrence predictor
by: Ru-Cui Yu, et al.
Published: (2018-01-01)

Retinoic acid increases proliferation of human osteoclast progenitors and inhibits RANKL-stimulated osteoclast differentiation by suppressing RANK.
by: Lijuan Hu, et al.
Published: (2010-01-01)

Identification of novel thymic epithelial cell subsets whose differentiation is regulated by RANKL and Traf6.
by: Nichole M Danzl, et al.
Published: (2014-01-01)

BICP0 Negatively Regulates TRAF6-Mediated NF-κB and Interferon Activation by Promoting K48-Linked Polyubiquitination of TRAF6
by: Chong Cao, et al.
Published: (2020-01-01)

Unkeito Suppresses RANKL-Mediated Osteoclastogenesis via the Blimp1–Bcl6 and NF-κB Signaling Pathways and Enhancing Osteoclast Apoptosis
by: Ke Fang, et al.
Published: (2022-07-01)

Rankl-independent induction of human osteoclast formation and bone resorption by TGF-beta
by: Itonaga, I, et al.
Published: (2002)

Secreted frizzled-related protein inhibits TNFalpha- or RANKL-dependent osteoclast formation
by: Hausler, K, et al.
Published: (2003)

Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
by: Häusler, K, et al.
Published: (2004)

Suppressive effects of (-)-tubaic acid on RANKL-induced osteoclast differentiation and bone resorption
by: Soomin Lim, et al.
Published: (2023-12-01)

Effect on Osteoclast Differentiation and ER Stress Downregulation by Amygdalin and RANKL Binding Interaction
by: Nguyen Minh Trang, et al.
Published: (2022-02-01)

DCIR suppresses osteoclastic proliferation and resorption by downregulating M-CSF and RANKL signaling
by: Tomonori Kaifu, et al.
Published: (2023-05-01)

RANKL neutralisation prevents osteoclast activation in a human ameloblastoma-bone model
by: Judith Pape, et al.
Published: (2022-12-01)

Experimental Study on the Inhibition of RANKL-Induced Osteoclast Differentiation In Vitro by Metformin Hydrochloride
by: Zhang Chen, et al.
Published: (2022-01-01)

TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation
by: Aseel Marahleh, et al.
Published: (2019-12-01)

Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway.
by: Asiri R Wijenayaka, et al.
Published: (2011-01-01)

18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis In Vivo and In Vitro by Blocking RANKL-Mediated RANK–TRAF6 Interactions and NF-κB and MAPK Signaling Pathways
by: Xiao Chen, et al.
Published: (2018-06-01)

Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 Signaling.
by: Mineko Tomomura, et al.
Published: (2015-01-01)

Correction: Identification of Novel Thymic Epithelial Cell Subsets Whose Differentiation Is Regulated by RANKL and Traf6
Published: (2014-01-01)